腫瘍病理鑑別診断アトラス　子宮頸癌　第2版

出版社： 文光堂
著者：
発行日： 2018-05-16
分野： 臨床医学：基礎  >  臨床病理学
ISBN： 9784830622533
シリーズ： 腫瘍病理鑑別診断アトラス
電子書籍版： 2018-05-16 （第2版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
発送目安：4～8営業日

16,500 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

16,500 円(税込)

購入する

商品紹介

腫瘍病理鑑別診断シリーズ「子宮頸癌」，待望の第2版．2009年の初版発行から約10年，WHO分類や取扱い規約も改訂を重ね，子宮頸部腫瘍の進行期分類や組織分類，細胞診の報告様式は大きく変わった．また最近では，病理医は婦人科医らとともに臨床に携わることも求められている．本改訂では，そうした状況を踏まえ，精選した病理写真を豊富に掲載し，定義や概念，診断上の要点を解説した．子宮頸部腫瘍を立体的に俯瞰できるものとなっている．

目次

  • 表紙
  • 執筆者一覧
  • 第2版の序
  • 第1版の序
  • 目次
  • 第1部 検鏡前の確認事項
  • I. WHO分類と子宮頸癌取扱い規約
  • 1. 一般的事項
  • 2. 扁平上皮病変
  • 3. 腺癌
  • 4. その他
  • II. ベセスダ分類改訂にみる細胞診の現状
  • III. 検体の取扱い方
  • 1. 検体の固定から病理診断科 / 部への提出まで
  • 2. 肉眼所見の観察
  • 3. 切り出しの基本と実際
  • 4. 病理診断報告書の記載とその臨床的意義
  • 第2部 組織型と診断の実際
  • I. 扁平上皮系腫瘍
  • 1. 扁平上皮内腫瘍 : SIL / CIN
  • 1. 分類の変遷
  • 2. LSIL / CIN1 ( mild dysplasia )
  • 3. HSIL / CIN2 ( moderate dysplasia )
  • 4. HSIL / CIN3 ( severe dysplasia / CIS )
  • 5. HPVとin situ hybridization ( ISH ) による検出
  • 6. 免疫組織化学マーカー
  • 7. 免疫組織化学の応用
  • 8. 鑑別診断
  • 2. 通常型扁平上皮癌
  • 3. 特殊型扁平上皮癌
  • 1. 乳頭状扁平上皮癌
  • 2. 類基底細胞癌
  • 3. コンジローマ様癌
  • 4. 疣 ( いぼ ) 状癌
  • 5. 扁平移行上皮癌
  • 6. リンパ上皮腫様癌
  • 7. 発癌メカニズム
  • 4. 良性腫瘍および腫瘍様病変
  • II. 腺系腫瘍
  • 1. 上皮内腺癌
  • 2. 通常型内頸部腺癌
  • 3. 粘液性癌
  • 1. 概念・分類
  • 2. 胃型粘液性癌
  • 3. 腸型粘液性癌
  • 4. 印環細胞型粘液性癌
  • 5. 特定不能な粘液性癌 ( 粘液性癌, NOS )
  • 4. 特殊型腺癌
  • 1. 漿液性癌
  • 2. 明細胞癌
  • 3. 中腎癌
  • 5. 良性腫瘍および腫瘍様病変
  • 1. 頸管ポリープ endocervical polyp
  • 2. Naboth ( ナボット ) 嚢胞 nabothian cyst
  • 3. トンネル・クラスター tunnel cluster
  • 4. 微小腺管過形成 microglandular hyperplasia ( MGH )
  • 5. 分葉状頸管腺過形成 lobular endocervical glandular hyperplasia ( LEGH )
  • 6. 中腎遺残および過形成 mesonephric remnants and hyperplasia
  • 7. Arias - Stella ( アリアス - ステラ ) 反応
  • 8. 卵管類内膜化生 tuboendometrioid metaplasia
  • III. その他の腫瘍
  • 1. 腺扁平上皮癌
  • 2. 腺様基底細胞癌
  • 3. 腺様嚢胞癌
  • 4. 神経内分泌腫瘍
  • 1. 用語に関する問題
  • 2. 低異型度神経内分泌腫瘍
  • 3. 高異型度神経内分泌癌
  • 4. 鑑別診断
  • 5. 未分化癌
  • 6. 間葉系腫瘍
  • 1. 平滑筋肉腫
  • 2. 横紋筋肉腫
  • 3. 胞巣状軟部肉腫
  • 4. 類上皮血管周囲細胞腫 ( PEComa )
  • 5. 筋線維芽細胞腫
  • 6. 間質性子宮内膜症
  • 7. その他の間葉系腫瘍, 腫瘍類似病変
  • 7. 上皮・間葉系混合腫瘍
  • 1. 腺筋腫
  • 2. 腺肉腫
  • 3. 癌肉腫
  • 8. 色素性病変
  • 1. 青色母斑
  • 2. 悪性黒色腫
  • 第3部 鑑別ポイント
  • I. SIL / CINと鑑別を要する病変
  • 1. ホルモン環境による変化
  • 2. 扁平上皮化生
  • 3. 尖圭コンジローマ
  • 4. 移行上皮化生
  • 5. 類基底細胞過形成
  • 6. 扁平上皮癌
  • 7. 重層性粘液産生上皮内病変 ( SMILE )
  • 8. 人工的な要素
  • II. コイロサイトーシス
  • III. 低分化型扁平上皮癌・腺癌の鑑別
  • IV. 上皮内腺癌と鑑別を要する病変
  • V. 頸部腺癌と体部腺癌の鑑別
  • VI. 鑑別診断における免疫組織化学の応用
  • 1. 非腫瘍性か腫瘍性かの鑑別に用いられるマーカー
  • 2. 腫瘍組織型の鑑別に用いられるマーカー
  • 3. 組織亜型の鑑別に用いられるマーカー
  • 4. 予後・転帰の推測に用いられるマーカー
  • 第4部 臨床との連携
  • I. 子宮頸癌の疫学
  • 1. 頸癌の歴史と疫学
  • 2. 頸癌前癌病変に対する考えの変遷
  • 3. 世界における頸癌の発生頻度
  • 4. 日本における頸癌の発生動向と予後
  • 5. 子宮 ( 頸 ) がん検診
  • 6. HPVの感染状況とワクチン
  • II. HPV感染の生物学と腫瘍原性
  • 1. ハイリスクHPV感染と頸癌
  • 2. 免疫応答とHPVの排除
  • 3. HPVによる免疫回避
  • 4. HPVに対する免疫寛容の成立機序
  • 5. HPV感染後の発癌のメカニズム
  • III. 子宮頸癌の進行期分類と治療方針・予後
  • IV. 組織学的治療効果判定
  • V. 病理診断報告書の記載
  • 1. 一般事項
  • 2. 生検
  • 3. 円錐切除, LEEP
  • 4. 手術
  • 索引
  • 奥付

おすすめ商品

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1部 検鏡前の確認事項

P.8 掲載の参考文献
1) Erickson BA, Olawaiye AB, Bermudez A et al : Cervix uteri. in : Amin MB, Edge SB, Greene FL et al (eds) : "AJCC Cancer Staging Manual", 8th ed. Springer, New York, 2017, pp649-659
 
2) Brieley JD, Gospodarowicz MK, Wittekind C (eds) : Union for International Cancer Control. TNM Classification of Malignant Tumours. 8th ed. Wiley Blackwell, Hoboken, 2017
 
3) Zaino RJ, Ward S, Delgado G et al : Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Cancer 69 : 1750-1758, 1992
PubMed
4) Baalbergen A, Ewing-Graham PC, Hop WC et al : Prognostic factors in adenocarcinoma of the uterine cervix. Gynecol Oncol 92 : 262-267, 2004
PubMed
5) Association of Directors of Anatomic and Surgical Pathology : Recommendations for the reporting of surgical specimens containing uterine cervical neoplasms. Mod Pathol 13 : 1029-1033, 2000
PubMed
6) The 1988 Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. Developed and approved at a National Cancer Institute Workshop, Bethesda, Maryland, U.S.A., December 12-13, 1988. J Reprod Med 34 : 779-785, 1989
 
7) Stoler M, Bergeron C, Colgan TJ et al : Squamous cell tumors and precursors. in Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed. IARC Press, Lyon, 2014
 
8) Darragh TM, Colgan TJ, Thomas Cox J et al : The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions : background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol 32 : 76-115, 2013
PubMed
9) Massad LS, Einstein MH, Huh WK et al : 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 17 : S1-S27, 2013
PubMed
10) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed. IARC Press, Lyon, 2014
 
11) Wells M, Ostor AG, Crum CP et al : Epithelial tumours. in Tavassoli FA, Stratton MR (eds) : "WHO Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs". IARC Press, Lyon, 2003, pp262-279
 
12) Kojima A, Mikami Y, Sudo T et al : Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol 31 : 664-672, 2007
PubMed
13) Mikami Y, Kiyokawa T, Moriya T et al : Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma ('adenoma malignum') and endocervical glandular hyperplasia : a study using oestrogen receptor and alpha-smooth muscle actin double immunostaining. Histopathology 46 : 130-136, 2005
PubMed
14) Mikami Y, McCluggage WG : Endocervical glandular lesions exhibiting gastric differentiation : an emerging spectrum of benign, premalignant, and malignant lesions. Adv Anat Pathol 20 : 227-237, 2013
PubMed
15) Holl K, Nowakowski AM, Powell N et al : Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias : Results from a European multinational epidemiological study. Int J Cancer 137 : 2858-2868, 2015
PubMed
P.16 掲載の参考文献
1) Levine PH, Elgert PA, Sun P et al : Atypical repair on Pap smears : clinicopathologic correlates in 647 cases. Diagn Cytopathol 33 : 214-217, 2005
PubMed
2) Schiffman M, Solomon D : Clinical practice. Cervical-cancer screening with human papillomavirus and cytologic cotesting. N Engl J Med 369 : 2324-2331, 2013
PubMed
3) Yang YJ, Trapkin LK, Demoski RK et al : The small blue cell dilemma associated with tamoxifen therapy. Arch Pathol Lab Med 125 : 1047-1050, 2001
PubMed
4) Massad LS, Einstein MH, Huh WK et al : 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 17 : S1-S27, 2013
PubMed
5) Zhao C, Florea A, Austin RM : Clinical utility of adjunctive high-risk human papillomavirus DNA testing in women with Papanicolaou test findings of atypical glandular cells. Arch Pathol Lab Med 134 : 103-108, 2010
PubMed
6) Sharpless KE, O'Sullivan DM, Schnatz PF : The utility of human papillomavirus testing in the management of atypical glandular cells on cytology. J Low Genit Tract Dis 13 : 72-78, 2009
 
7) Wilbur DC : Benign changes and mimics of malignant and premalignant epithelial lesions. in : Wilbur DC, Henry MR (eds) : "Gynecologic Cytopathology". CAP Press, Chicago, 2008, pp25-68
 
8) Mody DR : Glandular cell abnormalities. in : Mody DR (ed) : Diagnostic Pathology Cytopathology. Amirsys Publishing Inc, Salt Lake City, 2014, pp2-28
 
9) Roberts J, Thurloe J, Ekman D et al : The value of transformation zone cells in cytological detection of anal high grade squamous intraepithelial lesions (HSIL). Poster session presented at : 29th International Papillomavirus Conference and Public Health & Clinical Workshops. Seattle, Washington. Available at : www.hpv2014.org ; p.120 ; abstract # CS PP01.14.21-25 Aug 2014
 
10) Human papillomavirus-associated cancers-United States, 2004-2008. MMWR Morb Mortal Wkly Rep 61 : 258-261, 2012
PubMed
11) American Cancer Society : Anal cancer statistics. [Updated 5 May 2014 ; cited 11 Jul 2014]. Available at : http://www.cancer.org/cancer/analcancer/detailedguide/anal-cancer-what-is-key-statistics
 
12) Tong WW, Hillman RJ, Kelleher AD et al : Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults. HIV Med 15 : 65-76, 2014
PubMed
13) Panther LA, Wagner K, Proper J et al : High resolution anoscopy findings for men who have sex with men : inaccuracy of anal cytology as a predictor of histologic highgrade anal intraepithelial neoplasia and the impact of HIV serostatus. Clin Infect Dis 38 : 1490-1492, 2004
 
14) Darragh TM, Colgan TJ, Cox JT et al : The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions : background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med 136 : 1266-1297, 2012
PubMed
15) Gage JC, Schif fman M, Katki HA et al : Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test. J Nat Cancer Inst 2014 Jul 18 ; 106 (8). pii : dju153. doi : 10.1093/jnci/dju153. Print 2014 Aug.
 
P.23 掲載の参考文献
1) FIGO Committee on Gynecologic Oncology : FIGO staging for carcinoma of the vulva, cervix, and corpus uteri. Int J Gynaecol Obstet 125 : 97-98, 2014
PubMed
2) Brierley JD, Gospodarowicz MK, Wittekind C (eds) : The TNM Classification of Malignant Tumours, 8th ed. WILEY Blackwell, Oxford, 2017
 
3) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs. IARC Press, Lyon, 2014
 
4) Baalbergen A, Ewing-Graham PC, Hop WC et al : Prognostic factors in adenocarcinoma of the uterine cervix, Gynecol Oncol 92 : 262-267, 2004
PubMed
5) Lawrence WD, Abdul-Karim FW, Crum C et al : Recommendations for the reporting of surgical specimens containing uterine cervical neoplasms. Mod Pathol 13 : 1029-1033, 2000
 
6) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会, 日本放射線腫瘍学会 (編) : 子宮頸癌取扱い規約, 第3版. 金原出版, 東京, 2012
 

第2部 組織型と診断の実際

P.36 掲載の参考文献
1) 日本産科婦人科学会, 日本病理学会 (編) : 子宮頸癌取扱い規約 病理編, 第4版. 金原出版, 2017
 
2) Massad LS, Einstein MH, Huh WK et al : 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 17 : s1-s27, 2013
PubMed
3) Darragh TM, Colgan TJ, Cox JT et al : The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions : background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis 16 : 205-242, 2012
PubMed
4) 日本婦人科腫瘍学会 (編) : 子宮頸癌治療ガイドライン 2017年版. 金原出版, 2017
 
5) Meisels A, Fortin R, Roy M : Condylomatous lesions of the cervix. II. Cytologic, colposcopic and histopathologic study. Acta Cytol 21 : 379-390, 1977
PubMed
6) Ward BE, Saleh AM, Williams JV et al : Papillary immature metaplasia of the cervix : a distinct subset of exophytic cervical condyloma associated with HPV-6/11 nucleic acids. Mod Pathol 5 : 391-395, 1992
PubMed
7) Benevolo M, Mottolese M, Marandino F et al : Immunohistochemical expression of p16 (INK4a) is predictive of HRHPV infection in cervical low-grade lesions. Mod Pathol 19 : 384-391, 2006
 
8) Queiroz C, Silva TC, Alves VA et al : P16 (INK4a) expression as a potential prognostic marker in cervical pre-neoplastic and neoplastic lesions. Pathol Res Pract 202 : 77-83, 2006
PubMed
9) Focchi GR, Silva ID, Nogueira-de-Souza NC et al : Immunohistochemical expression of p16 (INK4A) in normal uterine cervix, nonneoplastic epithelial lesions, and low-grade squamous intraepithelial lesions. J Low Genit Tract Dis 11 : 98-104, 2007
PubMed
10) Looi ML, Dali AZ, Ali SA et al : Expression of p53, bcl-2 and Ki-67 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix. Anal Quant Cytol Histol 30 : 63-70, 2008
PubMed
11) Qiao X, Bhuiya TA, Spitzer M : Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis. J Low Genit Tract Dis 9 : 100-107, 2005
PubMed
12) Akasofu M, Oda Y : Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18. Virchows 425 : 593-602, 1995
PubMed
13) Dellas A, Schultheiss E, Almendral AC et al : Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia. Int J Cancer 74 : 421-425, 1997
PubMed
14) Mittal KR, Lin O, Chan W et al : Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV. Gynecol Oncol 58 : 289-294, 1995
PubMed
15) Jovanovic AS, McLachlin CM, Shen L et al : Postmeno pausal squamous atypia : a spectrum including "pseudokoilocytosis". Mod Pathol 8 : 408-412, 1995
 
16) 本山悌一 : 頸部上皮内腫瘍. 石倉浩, 本山悌一, 森谷卓也他 (編) : 子宮腫瘍病理アトラス. 文光堂, 2007, pp112-116
 
17) 三上芳喜 : 子宮頸部扁平上皮病変. 臨床と病理 26 : 245-253, 2008
 
18) Crum CP, Egawa K, Fu YS et al : Atypical immature metaplasia (AIM). A subset of human papilloma virus infection of the cervix. Cancer 51 : 2214-2219, 1983
 
19) Miyatake T, Ueda Y, Yoshino K et al : Clonality analysis and human papillomavirus infection in squamous metaplasia and atypical immature metaplasia of uterine cervix : is atypical immature metaplasia a precursor to cervical intraepithelial neoplasia 3? Int J Gynecol Pathol 26 : 180-187, 2007
PubMed
20) Park JJ, Genest DR, Sun D et al : Atypical immature metaplastic-like proliferations of the cervix : diagnostic reproducibility and viral (HPV) correlates. Hum Pathol 30 : 1161-1165, 1999
PubMed
21) Regauer S, Reich O : CK17 and p16 expression patterns distinguish (atypical) immature squamous metaplasia from high-grade cervical intraepithelial neoplasia (CIN III). Histopathology 50 : 629-635, 2007
PubMed
22) Geng L, Connolly DC, Isacson C et al : Atypical immature metaplasia (AIM) of the cervix : is it related to high-grade squamous intraepithelial lesion (HSIL) ? Hum Pathol 30 : 345-351, 1999
PubMed
23) Duggan MA, Akbari M, Magliocco AM : Atypical immature cervical metaplasia : immunoprofiling and longitudinal outcome. Hum Pathol 37 : 1473-1481, 2006
PubMed
24) Park JJ, Sun D, Quade BJ et al : Stratified mucin-producing intraepithelial lesions of the cervix : adenosquamous or columnar cell neoplasia? Am J Surg Pathol 24 : 1414-1419, 2000
PubMed
P.47 掲載の参考文献
1) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed. IARC Press, Lyon, 2014
 
2) 日本産科婦人科学会, 日本病理学会 (編) : 子宮頸癌取扱い規約 病理編, 第4版. 金原出版, 2017
 
3) 婦人科腫瘍委員会報告「2014年度患者年報」. 日産婦会誌 68 : 1117-1160, 2016
 
4) Benedetti-Panici P, Maneschi F, D'Andrea G et al : Early cervical carcinoma : the natural history of lymph node involvement redefined on the basis of through parametrectomy and giant section study. Cancer 88 : 2267-2274, 2000
 
5) Sakuragi N, Satoh C, Takeda N et al : Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stage IB, IIA and IIB cervical carcinoma treated with radical hysterectomy. Cancer 85 : 1547-1555, 1999
 
6) 日本産婦人科学会婦人科腫瘍委員会 : 婦人科腫瘍委員第41回治療年報. 日産婦会誌 60 : 1876-1889, 2008
 
7) 本山悌一 : 扁平上皮癌. 石倉浩, 本山悌一, 森谷卓也他 (編) : 子宮腫瘍病理アトラス. 文光堂, 2007, pp104-109
 
8) al Nafussi AI, Hughes DE : Histological features of CIN3 and their value in predicting invasive microinvasive squamous cell carcinoma. J Clin Patholol 47 : 799-804, 1994
 
9) Amin MB, Edge S, Greene F et al (eds) : AJCC Cancer Staging Manual, 8th ed. Springer, New York, 2017, pp649-659
 
10) Cibula D, Abu-Rustum NR, Dusek L et al : Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol Oncol 124 : 496-501, 2012
PubMed
11) Lentz SE, Muderspach LI, Felix JC et al : Identification of micrometastasis in histologically negative lymph nodes of early-stage cervical cancer patients. Obstet Gynecol 103 : 1204-1210, 2004
PubMed
12) Juretzka MM, Jensen KC, Longacre TA et al : Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis. Gynecol Oncol 93 : 107-111, 2004
PubMed
13) Lim D, Ip PPC, Cheung ANY et al : Immunohistochemical comparison of ovarian and uterine endometrioid carcinoma, endometrioid carcinoma with clear cell change, and clear cell carcinoma. Am J Surg Pathol 39 : 1061-1069, 2015
 
14) Ordonez NG : A word of caution regarding napsin A expression in squamous cell carcinomas of the lung. Am J Surg Pathol 36 : 396-401, 2011
 
15) Clement PB, Scully RE : Idiopathic postmenopausal decidual reaction of endometrium : A clinicopathological analysis four cases. Int J Gynecol Pathol 7 : 152-161, 1988
 
P.54 掲載の参考文献
1) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs. IARC Press, Lyon, 2014
 
2) 日本産科婦人科学会, 日本病理学会 (編) : 子宮頸癌取扱い規約 病理編, 第4版. 金原出版, 2017
 
3) Kokka F, Verma M, Singh N et al : Papillary squamotransitional cell carcinoma of the uterine cervix : report of three cases and review of the literature. Pathology 38 : 584-586, 2006
PubMed
4) Koenig C, Turnicky RP, Kankam CF et al : Papillary squamotransitional cell carcinoma of the cervix : a report of 32 cases. Am J Surg Pathol 21 : 915-921, 1997
PubMed
5) Martinez-Giron R, Martinez-Torre S, Mosquera-Martinez AJ : Basaloid squamous cell carcinoma of the uterine cervix : Cytological and histological features. Diagn Cytopathol 43 : 993-995, 2015
PubMed
6) Mutter GL, Prat J : Pathology of the Female Reproductive Tract. 3rd ed. Churchill Livingstone Elsevier, Edinburgh, 2014
 
7) Daroca PJ Jr, Dhurandhar HN : Basaloid carcinoma of uterine cervix. Am J Surg Pathol 4 : 235-239, 1980
PubMed
8) Kwon YS, Kim YM, Choi GW et al : Pure basaloid squamous cell carcinoma of the uterine cervix : a case report. J Korean Med Sci 24 : 542-545, 2009
PubMed
9) Ng WK, Cheung LK, Li AS : Warty (condylomatous) carcinoma of the cervix. A review of 3 cases with emphasis on thin-layer cytology and molecular analysis for HPV. Acta Cytol 47 : 159-166, 2003
PubMed
10) Degefu S, O'Quinn AG, Lacey CG et al : Verrucous carcinoma of the cervix : a report of two cases and literature review. Gynecol Oncol 25 : 37-47, 1986
 
11) Tseng CJ, Pao CC, Tseng LH et al : Lymphoepitheliomalike carcinoma of the uterine cervix : association with Epstein-Barr virus and human papillomavirus. Cancer 80 : 91-97, 1997
 
12) Chao A, Tsai CN, Hsueh S et al : Does Epstein-Barr virus play a role in lymphoepithelioma-like carcinoma of the uterine cervix? Int J Gynecol Pathol 28 : 279-285, 2009
PubMed
P.62 掲載の参考文献
1) Fu YS : Pathology of the Uterine Cervix, Vagina, and Vulva, 2nd ed. Saunders, Philadelphia, 2002, p283
 
2) Jovanovic AS, McLachlin CM, Shen L et al : Postmenopausal squamous atypia : a spectrum including "pseudokoilocytosis". Mod Pathol 8 : 408-412, 1995
PubMed
3) Crum CP, Rose PG : Cervical squamous neoplasia. in Crum CP, Lee KR (eds) : "Diagnostic Gynecologic and Obstetric Pathology". Elsevier Saunders, Philadelphia, 2006, p310
 
4) Weir MM, Bell DA, Young RH : Transitional cell metaplasia of the uterine cervix and vagina : an underrecognized lesion that may be confused with high-grade dysplasia. A report of 59 cases. Am J Surg Pathol 21 : 510-517, 1997
PubMed
5) Boon ME, van Dunne FM, Vardaxis NJ : Recognition of atypical reserve cell hyperplasia in cervical smears and itsdiagnostic significance. Mod Pathol 8 : 786-794, 1995
PubMed
6) Iaconis L, Hyjek E, Ellenson LH et al : p16 and Ki-67 immunostaining in atypical immature squamous metaplasia of the uterine cervix : correlation with human papillomavirus detection. Arch Pathol Lab Med 131 : 1343-1349, 2007
PubMed
P.70 掲載の参考文献
1) Friedell GH, Mc KD : Adenocarcinoma in situ of the endocervix. Cancer 6 : 887-897, 1953
 
2) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed. IARC Press, Lyon, 2014
 
3) Clement PB, Young RH : Atlas of Gynecologic Surgical Pathology, 3rd ed. Saunders/Elsevier, London, 2014
 
4) Tavassoli FA, Deville P (eds) : WHO Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs. IARC Press, Lyon, 2003
 
5) 日本婦人科学会, 日本病理学会, 日本医学放射線学会, 日本放射線腫瘍学会 (編) : 子宮頸癌取扱い規約, 第3版. 金原出版, 2012
 
6) McCluggage WG : New developments in endocervical glandular lesions. Histopathology 62 : 138-160, 2013
PubMed
7) Madeleine MM, Daling JR, Schwartz SM et al : Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol Biomarkers Prev 10 : 171-177, 2001
PubMed
8) Ursin G, Peters RK, Henderson BE et al : Oral contraceptive use and adenocarcinoma of cervix. Lancet 344 : 1390-1394, 1994
PubMed
9) Salani R, Puri I, Bristow RE : Adenocarcinoma in situ of the uterine cervix : a metaanalysis of 1278 patients evaluating the predictive value of conization margin status. Am J Obstet Gynecol 200 : 182, 2009
PubMed
10) Loureiro J, Oliva E : The spectrum of cervical glandular neoplasia and issues in differential diagnosis. Arch Pathol Lab Med 138 : 453-483, 2014
PubMed
11) Wilbur DC : Practical issues related to uterine pathology : in situ and invasive cervical glandular lesions and their benign mimics : emphasis on cytology-histology correlation and interpretive pitfalls. Mod Pathol 29 (Suppl 1) : S1-S11, 2016
 
12) 濱田智美, 清川貴子 : 頸部腺癌をめぐる問題. 病理と臨床 26 : 245-262, 2008
 
13) Mikami Y, McCluggage WG : Endocervical glandular lesions exhibiting gastric differentiation : an emerging spectrum of benign, premalignant, and malignant lesions. Adv Anat Pathol 20 : 227-237, 2013
PubMed
14) Schlesinger C, Silverberg SG : Endocervical adenocarcinoma in situ of tubal type and its relation to atypical tubal metaplasia. Int J Gynecol Pathol 18 : 1-4, 1999
PubMed
15) Zaino RJ : Glandular lesions of the uterine cervix. Mod Pathol 13 : 261-274, 2000
PubMed
16) McCluggage WG, Shah R, Connolly LE et al : Intestinaltype cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2. Int J Gynecol Pathol 27 : 92-100, 2008
 
17) Park JJ, Sun D, Quade BJ et al : Stratified mucin-producing intraepithelial lesions of the cervix : adenosquamous or columnar cell neoplasia? Am J Surg Pathol 24 : 1414-1419, 2000
PubMed
18) Lastra RR, Park KJ, Schoolmeester JK : Invasive Stratified Mucin-producing Carcinoma and Stratified Mucin-producing Intraepithelial Lesion (SMILE) : 15 Cases Presenting a Spectrum of Cervical Neoplasia With Description of a Distinctive Variant of Invasive Adenocarcinoma. Am J Surg Pathol 40 : 262-269, 2016
PubMed
P.76 掲載の参考文献
1) Wilbur DC, Colgan TJ, Ferenczy TJ et al : Glandular tumours and precursors. in Kurman RM, Carcangiu ML, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed. IARC Press, Lyon, 2014
 
2) Young RH, Clement PB : Endocervical adenocarcinoma and its variants : their morphology and differential diagnosis. Histopathology 41 : 185-207, 2002
PubMed
3) Holl K, Nowakowski AM, Powell N et al : Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias : Results from a European multinational epidemiological study. Int J Cancer 137 : 2858-2868, 2015
PubMed
4) 日本産婦人科学会婦人科腫瘍委員会 : 2014年度患者年報. 日産婦会誌 68 : 1117-1160, 2016
 
5) Kojima A, Mikami Y, Sudo T et al : Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol 31 : 664-672, 2007
PubMed
6) Wang SS, Sherman ME, Hildesheim A et al : Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 100 : 1035-1044, 2004
PubMed
7) 山本嘉一郎 : 子宮頸部腺癌. 日産婦会誌 58 : 249-252, 2006
 
8) An HJ, Kim KR, Kim IS et al : Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma : a population-based study. Mod Pathol 18 : 528-534, 2005
PubMed
9) Mikami Y, McCluggage WG : Endocervical glandular lesions exhibiting gastric differentiation : an emerging spectrum of benign, premalignant, and malignant lesions. Adv Anat Pathol 20 : 227-237, 2013
PubMed
10) 日本産婦人科学会婦人科腫瘍委員会 : 第57回治療年報. 日産婦会誌 68 : 1161-1231, 2016
 
11) 日本産婦人科学会, 日本病理学会, 日本医学放射線学会 (編) : 子宮頸癌取扱い規約, 改訂第2版. 金原出版, 1997
 
12) 日本産婦人科学会, 日本病理学会, 日本医学放射線学会, 日本放射線腫瘍学会 (編) : 子宮頸癌取扱い規約, 第3版. 金原出版, 2012
 
13) Riethdorf L, Riethdorf S, Lee KR et al : Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. Hum Pathol 33 : 899-904, 2002
PubMed
14) McCluggage WG, Jenkins D : p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol 22 : 231-235, 2003
PubMed
15) Mikami Y, Kiyokawa T, Hata S et al : Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions : a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'. Mod Pathol 17 : 962-972, 2004
PubMed
16) Kamoi S, AlJuboury MI, Akin MR et al : Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas : another viewpoint. Int J Gynecol Pathol 21 : 217-223, 2002
PubMed
17) Young RH, Clement PB : Tumorlike lesions of the uterine cervix. in Clement PB, Young RH (eds) : "Tumors and Tumorlike Lesions of the Uterine Corpus and Cervix". Churchill Livngstone, New York, 1993, pp1-50
 
18) Young RH, Scully RE : Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases. Cancer 63 : 1773-1779, 1989
PubMed
19) McCluggage WG : New developments in endocervical glandular lesions. Histopathology 62 : 138-160, 2013
PubMed
P.85 掲載の参考文献
1) Ishii K, Hosaka N, Toki T et al : A new view of the so-called adenoma malignum of the uterine cervix. Virchows Archiv 432 : 315-322, 1998
PubMed
2) Nucci MR, Clement PB, Young RH : Lobular endocervical glandular hyperplasia, not otherwise specified : a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum. Am J Surg Pathol 23 : 886-891, 1999
 
3) Mikami Y, Hata S, Fujiwara K et al : Florid endocervical glandular hyperplasia with intestinal and pyloric gland metaplasia : worrisome benign mimic of "adenoma malignum". Gynecol Oncol 74 : 504-511, 1999
PubMed
4) Mikami Y, Kiyokawa T, Hata S et al : Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions : a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'. Mod Pathol 17 : 962-972, 2004
PubMed
5) Kojima A, Mikami Y, Sudo T et al : Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol 31 : 664-672, 2007
PubMed
6) Park KJ, Kiyokawa T, Soslow RA et al : Unusual endocervical adenocarcinomas : an immunohistochemical analysis with molecular detection of human papillomavirus. Am J Surg Pathol 35 : 633-646, 2011
PubMed
7) Karamurzin YS, Kiyokawa T, Parkash V et al : Gastric-type Endocervical Adenocarcinoma : An Aggressive Tumor With Unusual Metastatic Patterns and Poor Prognosis. Am J Surg Pathol 39 : 1449-1457, 2015
PubMed
8) Kawauchi S, Kusuda T, Liu XP et al : Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma? : a comparative molecular-genetic and immunohistochemical study. Am J Surg Pathol 32 : 1807-1815, 2008
PubMed
9) Kuragaki C, Enomoto T, Ueno Y et al : Mutations in the STK11 gene characterize minimal deviation adenocarcinoma of the uterine cervix. Lab Invest 83 : 35-45, 2003
PubMed
10) Holl K, Nowakowski AM, Powell N et al : Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias : Results from a European multinational epidemiological study. Int J Cancer 137 : 2858-2868, 2015
PubMed
11) Mikami Y, Kiyokawa T, Sasajima Y et al : Reappraisal of synchronous and multifocal mucinous lesions of the female genital tract : a close association with gastric metaplasia. Histopathology 54 : 184-191, 2009
PubMed
12) Kawakami F, Mikami Y, Sudo T et al : Cytologic features of gastric-type adenocarcinoma of the uterine cervix. Diagn Cytopathol 43 : 791-796, 2015
PubMed
13) Fulmer CG, Hoda RS, Pirog EC et al : Cytomorphology of Gastric-Type Cervical Adenocarcinoma on a ThinPrep Pap Test : Report of a p16-Positive Tumor Case. Diagn Cytopathol 44 : 710-713, 2016
PubMed
14) Stolnicu S, Barsan I, Hoang L et al : International Endocervical Adenocarcinoma Criteria and Classification (IECC) : A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix. Am J Surg Pathol 42 : 214-226, 2018
PubMed
15) Mikami Y, Minamiguchi S, Teramoto N et al : Carbonic anhydrase type IX expression in lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix. Pathol Res Pract 209 : 173-178, 2013
PubMed
16) Carleton C, Hoang L, Sah S et al : A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas. Am J Surg Pathol 40 : 636-644, 2016
 
17) An HJ, Kim KR, Kim IS et al : Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma : a population-based study. Mod Pathol 18 : 528-534, 2005
PubMed
18) McCluggage WG, Shah R, Connolly LE et al : Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2. Int J Gynecol Pathol 27 : 92-100, 2008
PubMed
P.91 掲載の参考文献
1) Zhou C, Gilks CB, Hayes M et al : Papillary serous carcinoma of the uterine cervix : a clinicopathologic study of 17 cases. Am J Surg Pathol 22 : 113-120, 1988
 
2) Zhou C, Matisic JP, Clement PB et al : Cytologic features of papillary serous adenocarcinoma of the uterine cervix. Cancer 81 : 98-104, 1997
PubMed
3) Nofech-Mozes S, Rasty G, Ismiil N et al : Immunohistochemical characterization of endocervical papillary serous carcinoma. Int J Gynecol Cancer 16 (Suppl 1) : 286-292, 2006
PubMed
4) Pirog EC, Kleter B, Olgac S et al : Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 157 : 1055-1062, 2000
PubMed
5) Duggan MA, McGregor SE, Benoit JL et al : The human papillomavirus status of invasive cervical adenocarcinoma : a clinicopathological and outcome analysis. Hum Pathol 26 : 319-325, 1995
PubMed
6) Hill EC : Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina. Am J Obstet Gynecol 116 : 470-484, 1973
 
7) Reich O, Tamussino K, Lahousen M et al : Clear cell carcinoma of the uterine cervix : pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol. Gynecol Oncol 76 : 331-335, 2000
 
8) Thomas MB, Wright JD, Leiser AL et al : Clear cell carcinoma of the cervix : a multi-institutional review in the post-DES era. Gynecol Oncol 109 : 335-339, 2008
PubMed
9) Mentrikoski MJ, Wendroth SM, Wick MR : Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology : utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin. Appl Immunohistochem Mol Morphol 22 : 635-641, 2004
 
10) Boyd J, Takahashi H, Waggoner SE et al : Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero. Cancer 77 : 507-513, 1996
PubMed
11) Hajek RA, King DW, Hernandez-Valero MA et al : Detection of chromosomal aberrations by fluorescence in situ hybridization in cervicovaginal biopsies from women exposed to diethylstilbestrol in utero. Int J Gynecol Cancer 16 : 318-324, 2006
PubMed
12) Kocken M, Baalbergen A, Snijders PJ et al : High-risk human papillomavirus seems not involved in DES-related and of limited importance in nonDES related clear cell carcinoma of the cervix. Gynecol Oncol 122 : 297-302, 2011
 
13) Ueno S, Sudo T, Oka N et al : Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma. Int J Gynecol Cancer 23 : 1084-1091, 2013
PubMed
14) Clement PB, Young RH, Keh P et al : Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component. Am J Surg Pathol 19 : 1158-1171, 1995
 
15) Silver SA, Devouassoux-Shisheboran M, Mezzetti TP et al : Mesonephric adenocarcinomas of the uterine cervix : a study of 11 cases with immunohistochemical findings. Am J Surg Pathol 25 : 379-387, 2001
PubMed
16) Bague S, Rodriguez IM, Prat J : Malignant mesonephric tumors of the female genital tract : a clinicopathologic study of 9 cases. Am J Surg Pathol 28 : 601-607, 2004
PubMed
17) McCluggage WG, Oliva E, Herrington CS et al : CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus : CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. Histopathology 43 : 144-150, 2003
 
18) Mirkovic J, Sholl LM, Garcia E et al : Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract. Mod Pathol 28 : 1504-1514, 2015
PubMed
P.104 掲載の参考文献
1) Tavassoli FA, Devilee P (eds) : WHO Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs, 3rd ed. IARC Press, Lyon, 2003, pp276-277
 
2) Kurman RJ, Carcangiu ML, Herrington S et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed. IARC Press, Lyon, 2014, pp189-194
 
3) 日本産科婦人科学会・日本病理学会 (編) : 子宮頸癌取扱い規約 病理編, 第4版, 金原出版, 2017, pp40-45
 
4) Greeley C, Schroeder S, Silverberg SG : Microglandular hyperplasia of the cervix : a true "pill" lesion? Int J Gynecol Pathol 14 : 50-54, 1995
PubMed
5) Michal Z : Hormone Receptors in Microglandular Hyperplasia of the Uterine Cervix. Int J Gynecol Pathol (Letters to the Editor) 21 : 424-425, 2002
 
6) Nucci MR, Clement PB, Young RH : Lobular endocervical glandular hyperplasia, not otherwise specified : a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum. Am J Surg Pathol 23 : 886-891, 1999
 
7) Mikami Y, Kiyokawa T, Hata S et al : Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions : a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'. Mod Pathol 17 : 962-972, 2004
PubMed
8) Matsubara A, Sekine S, Ogawa R et al : Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations. Am J Surg Pathol 38 : 370-376, 2014
PubMed
9) Mikami Y, Hata S, Melamed J et al : Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype. Histopathology 39 : 364-372, 2001
PubMed
10) Nucci MR : Pseudoneoplastic Glandular Lesions of the Uterus Cervix : A selective Review. Int J Gynecol Pathol 33 : 330-338, 2014
PubMed
11) Ferry JA, Scully RE : Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases. Am J Surg Pathol 14 : 1100-1111, 1990
PubMed
12) Howitt BE, Emori MM, Drapkin R et al : GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract. Am J Surg Pathol 39 : 1411-1419, 2015
PubMed
13) Arias-Stella J : A topographic study of uterine epithelial atypia associated with chorionic tissue : demonstration of alteration in the endocervix. Cancer 12 : 782-790, 1959
 
14) Schneider V : Arias-Stella reaction of the endocervix : frequency and location. Acta Cytol 25 : 224-228, 1981
 
15) Nucci MR, Young RH : Arias-Stella Reaction of the Endocervix : A Report of 18 Cases With Emphasis on Its Varied Histology and Differential Diagnosis. Am J Surg Pathol 28 : 608-612, 2004
 
16) Ismail SM : Cone biopsy causes cervical endometriosis and tubo-endometrioid metaplasia. Histopathology 18 : 107-114, 1991
PubMed
17) Kurman RJ, Ellenson LH, Ronnett BM (eds) : Benign diseases of the cervix. in "Blaustein's Pathology of the Female Genital Tract", 6th ed. Springer, New York, 2011, pp166-169
 
P.113 掲載の参考文献
1) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs. IARC Press, Lyon, 2014, pp194-195
 
2) Ueda Y, Miyatake T, Okazawa M et al : Clonality and HPV infection analysis of concurrent glandular and squamous lesions and adenosquamous carcinomas of the uterine cervix. Am J Clin Pathol 130 : 389-400, 2008
PubMed
3) 婦人科腫瘍委員会報告2014年度患者年報. 日産婦会誌 68 : 1117-1115, 2016
 
4) Farley JH, O'Boyle JD, Carlson JW et al : Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer 97 : 2196-2202, 2003
 
5) Lai CH, Chou HH, Chang CJ et al : Clinical implications of human papillomavirus genotype in cervical adeno-adenosquamous carcinoma. Eur J Gynecol Cancer 49 : 633-641, 2013
 
6) Gray HJ, Garcia R, Tamimi HK et al : Glassy cell carcinoma of the cervix revisited. Gynecol Oncol 85 : 274-277, 2002
PubMed
7) Hopkins MP, Morley GW : Glassy cell adenocarcinoma of the uterine cervix. Am J Obstet Gynecol 190 : 67-70, 2004
PubMed
8) Garg MM, Arora VK : Clear cell adenosquamous carcinoma of the cervix : a case report with discussion of the differential diagnosis. Int J Gynecol Pathol 31 : 294-296, 2012
PubMed
9) Fujiwara H, Mitchell MF, Arseneau J et al : Clear cell adenosquamous carcinoma of the cervix. An aggressive tumor associated with human papillomavirus-18. Cancer 76 : 1591-1600, 1995
PubMed
10) Kurman RJ, Hendrick Ellenson L, Ronnet BM (eds) : Blaustein's Pathology of Female Geintal Tract, 6th ed. Springer, Baltimore, 2011, pp286-288
 
11) Costa MJ, Kenny MB, Hewan-Lowe K et al : Glassy cell features in adenosquamous carcinoma of the uterine cervix. Histologic, ultrastructural, Immunohistochemical and clinical finding. Am J Clin Pathol 96 : 520-528, 1991
 
12) Langlois NE, Ellul B, Miller ID : A study of the value and prognostic significance of mucin staining in squamous cell carcinoma of the uterine cervix. Histopathology 28 : 175-178, 1996
PubMed
13) Lennerz JK, Perry A, Mills JC et al : Mucoepidermoid carcinoma of the cer vix : another tumor with the t (11 ; 19) -associated CRTC1-MAML2 gene fusion. Am J Surg Pathol 33 : 835-843, 2009
 
14) Kato N, Katayama Y, Kaimori M t al : Glassy Cell carcinoma of the uterine cervix : Histochemical, Immunohistochemical and molecular genetic observations. Int J Gynecol Pathol 21 : 134-140, 2002
 
15) Yoshida Y, Sano T, Oyama T et al : Prevalence, viral load, and physical status of HPV16 and 18 in cervical adenosquamous carcinoma. Virchows Arch 455 : 253-259, 2009
 
16) Katagiri A, Nakayama K, Rahman M et al : Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix. Int J Gynecol Cancer 22 : 208-212, 2012
PubMed
P.117 掲載の参考文献
1) Colgan TJ, Kim KR, Hirschowitz L et al : Other epithelial tumours. in Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed. IARC Press, Lyon, 2014, pp194-196
 
2) Baggish MS, Woodruff JD : Adenoid-basal carcinoma of the cervix. Obstet Gynecol 28 : 213-218, 1966
PubMed
3) van Dinh T, Woodruff JD : Adenoid cystic and adenoid basal carcinomas of the cervix. Obstet Gynecol 65 : 705-709, 1985
PubMed
4) Ferry JA, Scully RE : "Adenoid cystic" carcinoma and adenoid basal carcinoma of the uterine cervix. A study of 28 cases. Am J Surg Pathol 12 : 134-144, 1988
PubMed
5) Russell MJ, Fadare O : Adenoid basal lesions of the uterine cervix : evolving terminology and clinicopathological concepts. Diagn Pathol 1 : 18, 2006
 
6) Brainard JA, Hart WR : Adenoid basal epitheliomas of the uterine cervix-A reevaluation of distinctive cervical basaloid lesions currently classified as adenoid basal carcinoma and adenoid basal hyperplasia. Am J Surg Pathol 22 : 965-975, 1998
PubMed
7) Baggish MS, Woodruff JD : Adenoid basal lesions of the cervix. Obstet Gynecol 37 : 807-819, 1971
PubMed
8) Parwani AV, Sehdev AES, Kurman RJ et al : Cervical adenoid basal tumors comprised of adenoid basal epithelioma associated with various types of invasive carcinoma : Clincopathologic features, human papillomavirus DNA detection, and P16 expression. Hum Pathol 36 : 82-90, 2005
 
9) Takeshima Y, Amatya VJ, Nakayori F et al : Co-existent carcinosarcoma and adenoid basal carcinoma of the uterine cervix and correlation with human papillomavirus infection. Int J Gynecol Pathol 21 : 186-190, 2002
PubMed
10) Grayson W, Taylor L, Cooper K : Detection of integrated high risk human papillomavirus in adenoid cystic carcinoma of the uterine cervix. J Clin Pathol 49 : 805-809, 1996
 
11) Chen TD, Chuang HC, Lee LY : Adenoid basal carcinoma of the uterine cervix : clinicopathologic features of 12 cases with reference to CD117 expression. Int J Gynecol Pathol 31 : 25-32, 2012
PubMed
12) Kerdraon O, Cornelius A, Farine M-O et al : Adenoid basal hyperplasia of the uterine cervix : a lesion of reserve cell type, distinct from adenoid basal carcinoma. Hum Pathol 43 : 2255-2265, 2012
PubMed
13) Stoler M, Kim KR, Bergeron C et al : Squamous cell tumours and precursors. in Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed. IARC Press, Lyon 2014, pp172-182
 
P.121 掲載の参考文献
1) Colgan TJ, Kim KR, Hirschowitz L et al : in Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed. IARC Press, Lyon, 2014, pp194-196
 
2) Kurmann RJ, Ronnett BM, Sherman ME et al : AFIP Atlas of Tumor Pathology Series 4, Tumors of the Cervix, Vagina, and Vulva. ARP, Washington, 2010, pp202-203
 
3) Grayson W, Taylor LF, Cooper K : Adenoid cystic and adenoid basal carcinoma of the uterine cervix : comparative morphologic, mucin, and immunohistochemical profile of two rare neoplasms of putative 'reserve cell' origin. Am J Surg Pathol 23 : 448-458, 1999
PubMed
4) Xing D, Schoolmeester JK, Ren Z et al : Lower Female Genital Tract Tumors With Adenoid Cystic Differentiation : P16 Expression and High-risk HPV Detection. Am J Surg Pathol 40 : 529-536, 2016
PubMed
5) Parwani AV, Smith Sehdev AE, Kurman RJ et al : Cervical adenoid basal tumors comprised of adenoid basal epithelioma associated with various types of invasive carcinoma : clinicopathologic features, human papillomavirus DNA detection, and p16 expression. Hum Pathol 36 : 82-90, 2005
PubMed
6) Bishop JA, Ogawa T, Stelow EB et al : Human papillomavirus-related carcinoma with adenoid cystic-like features : a peculiar variant of head and neck cancer restricted to the sinonasal tract. Am J Surg Pathol 37 : 836-844, 2013
PubMed
7) Brill LB 2nd, Kanner WA, Fehr A et al : Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod Pathol 24 : 1169-1176, 2011
PubMed
8) Shi X, Wu S, Huo Z et al : Co-existing of adenoid cystic carcinoma and invasive squamous cell carcinoma of the uterine cervix : a report of 3 cases with immunohistochemical study and evaluation of human papillomavirus status. Diagn Pathol 10 : 145, 2015
PubMed
9) Ferry JA, Scully RE : "Adenoid cystic" carcinoma and adenoid basal carcinoma of the uterine cervix. Am J Surg Pathol 12 : 134-144, 1988
PubMed
10) Grayson W, Cooper K : A reappraisal of "basaloid carcinoma" of the cervix, and the differential diagnosis of basaloid cervical neoplasms. Adv Anat Pathol 9 : 290-300, 2002
 
11) Chen TD, Chuang HC, Lee LY : Adenoid basal carcinoma of the uterine cervix : clinicopathologic features of 12 cases with reference to CD117 expression. Int J Gynecol Pathol 31 : 25-32, 2012
PubMed
12) Emanuel P, Wang B, Wu M et al : p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Mod Pathol 18 : 645-650, 2005
PubMed
P.128 掲載の参考文献
1) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs. IARC Press, Lyon, 2014
 
2) 日本産科婦人科学会, 日本病理学会 (編) : 子宮頸癌取扱い規約 病理編, 第4版. 金原出版, 2017
 
3) Bosman FT, Carneiro F, Hruban R et al (eds) : WHO Classification of Tumours of the Digestive System. IARC Press, Lyon, 2010
 
4) Gilks CB, Young RH, Gersell DJ et al : Large cell neuroendocrine carcinoma of the uterine cervix : a clinicopathologic study of 12 cases. Am J Surg Pathol 21 : 905-914, 1997
PubMed
5) Kurman RJ, Norris HJ, Wilkinson EJ (eds) : AFIP Atlas of Tumor Pathology Series 4, Tumors of the Cervix, Vagina, and Vulva. ARP Washington, DC, 1992
 
6) Koch CA, Azumi N, Furlong MA et al : Carcinoid syndrome caused by an atypical carcinoid of the uterine cervix. J Clin Endocrinol Metab 84 : 4209-4213, 1999
PubMed
7) Soga J, Osaka M, Yakuwa Y : Gut-endocrinomas (carcinoids and related endocrine variants) of the uterine cervix : an analysis of 205 reported cases. J Exp Clin Cancer Res 20 : 327-334, 2001
 
8) Wistuba II, Thomas B, Behrens C et al : Molecular abnormalities associated with endocrine tumors of the uterine cervix. Gynecol Oncol 72 : 3-9, 1999
PubMed
9) Straughn JM Jr, Richter HE, Conner MG et al : Predictors of outcome in small cell carcinoma of the cervix-a case series. Gynecol Oncol 83 : 216-220, 2001
PubMed
10) Gersell DJ, Mazoujian G, Mutch DG et al : Small-cell undifferentiated carcinoma of the cervix. A clinicopathologic, ultrastructural, and immunocytochemical study of 15 cases. Am J Surg Pathol 12 : 684-698, 1988
PubMed
11) Abeler VM, Holm R, Nesland JM et al : Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients. Cancer 73 : 672-677, 1994
PubMed
12) Park HJ, Choi YM, Chung CK et al : Pap smear screening for small cell carcinoma of the uterine cervix : a case series and review of the literature. J Gynecol Oncol 22 : 39-43, 2011
PubMed
13) Moss EL, Pearmain P, Askew S et al : Neuroendocrine carcinoma of the cervix : a review of clinical management and survival. Int J Gynecol Cancer 21 (Suppl 3), 2011
 
14) Wang PH, Liu YC, Lai CR et al : Small cell carcinoma of the cervix : analysis of clinical and pathological findings. Eur J Gynaecol Oncol 19 : 189-192, 1998
 
15) Seckl MJ, Mulholland PJ, Bishop AE et al : Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix. N Engl J Med 341 : 733-736, 1999
 
16) Bermudez A, Vighi S, Garcia A et al : Neuroendocrine cervical carcinoma : a diagnostic and therapeutic challenge. Gynecol Oncol 82 : 32-39, 2001
PubMed
17) Mannion C, Park WS, Man YG et al : Endocrine tumors of the cervix : morphologic assessment, expression of human papillomavirus, and evaluation for loss of heterozygosity on 1p, 3p, 11q, and 17p. Cancer 83 : 1391-1400, 1998
PubMed
18) McCluggage WG, Kennedy K, Busam KJ : An immunohistochemical study of cervical neuroendocrine carcinomas : Neoplasms that are commonly TTF1 positive and which may express CK20 and P63. Am J Surg Pathol 34 : 525-532, 2010
PubMed
19) Takizawa N, Ohishi Y, Hirahashi M et al : Molecular characteristics of colorectal neuroendocrine carcinoma ; similarities with adenocarcinoma rather than neuroendocrine tumor. Hum Pathol 46 : 1890-1900, 2015
PubMed
20) Yachida S, Vakiani E, White CM et al : Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol 36 : 173-184, 2012
PubMed
21) Stoler MH, Mills SE, Gersell DJ et al : Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer. Am J Surg Pathol 15 : 28-32, 1991
PubMed
22) Kawauchi S, Okuda S, Morioka H et al : Large cell neuroendocrine carcinoma of the uterine cervix with cytogenetic analysis by comparative genomic hybridization : a case study. Hum Pathol 36 : 1096-1100, 2005
PubMed
23) 大場岳彦, 石川雄一 : 肺神経内分泌腫瘍の分類と組織診断. 病理と臨床 28 : 151-155, 2010
Medical*Online
24) 元井紀子, 石川雄一 : 肺に発生する神経内分泌腫瘍. 病理と臨床 29 : 444-450, 2011
Medical*Online
25) Masoura S, Kour tis A, Kalogiannidis I et al : Primary primitive neuroectodermal tumor of the cervix confirmed with molecular analysis in a 23-year-old woman : A case report. Pathol Res Pract 208 : 245-249, 2012
 
P.133 掲載の参考文献
1) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed. IARC Press, Lyon, 2014, pp194-196
 
2) Euscher E, Malpica A : Use of immunohistochemistry in the diagnosis of miscellaneous and metastatic tumors of the uterine corpus and cervix. Semin Diagn Pathol 31 : 233-257, 2014
 
3) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed., IARC Press, Lyon, 2014, pp132-133
 
4) Saad RS, Mashhour M, Noftech-Mozes S et al : P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin. Inf J Gynecol Pathol 31 : 57-65, 2012
PubMed
5) Rekhi B, Patil B, Deodhar KK et al : Spectrum of neuroendocrine carcinomas of the uterine cervix including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India. Ann Diagn Pathol 17 : 1-9, 2013
 
6) Duggal R, Srinivasan R : Primary amelanotic melanoma of the cervix : case report with reiew of literature. J Gynecol Oncol 21 : 199-202, 2010
 
7) Coulson LE, Kong CS, Zaloudek C : Epithelioid trophoblastic tumor of the uterus in a postmenopausal woman a case report and review of the literature. Am J Surg Pathol 24 : 1558-1562, 2000
 
8) Mashriqi N, Gujjarlapudi JK, Sidhu J et al : Ewing's sarcoma of the cervix, a diagnostic dilemma : a case report and review of the literature. J Med Case Rep 9 : 255, 2015
 
P.139 掲載の参考文献
1) Nucci MR, Carcangiu ML, Nielsen GP et al : Mesenchymal tumours and tumour-like lesions. in Kurman RJ, Carcangiu M, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed. IARC Press, Lyon, 2014, pp198-202
 
2) Wilkinson N, Rollason TP : Recent advance in the pathology of smooth muscle tumor of the uterus. Histopathology 39 : 331-341, 2001
 
3) Daya DA, Scully RE : Sarcoma botryoides of the uterine cervix in young women : a clinicopathological study of 13 cases. Gynecol Oncol 29 : 290-304, 1988
PubMed
4) Zeisler H, Mayerhofer K, Joura EA et al : Embryonal rhabdomyosarcoma of the uterine cervix : case report and review of the literature. Gynecol Oncol 69 : 78-83, 1998
PubMed
5) Ordonez JL, Osuna D, Garcia-Dominguez DJ et al : The clinical relevance of molecular genetics in soft tissue sarcomas. Adv Anat Pathol 17 : 162-181, 2010
PubMed
6) Dehner LP, Jarzembowski JA, Hill DA : Embryonal rhabdomyosarcoma of the uterine cervix. A report of 14 cases and a discussion of its unusual clinicopathological association. Mod Pathol 25 : 602-614, 2012
 
7) Hasegawa K, Ichikawa R, Ishii R et al : A case of primary alveolar soft part sarcoma of the uterine cervix and a review of the literature. In J Clin Oncol 16 : 751-758, 2011
 
8) Roma AA, Yang B, Senior ME et al : TTF3 immunoreactivity in alveolar soft part sarcoma of the uterine cervix : case report. Int J Gynecol 24 : 131-135. 2005
 
9) Ladanyi M, Lui MY, Antonescu CR et al : The der (17) t (X ; 17) (p11 ; q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 20 : 48-57, 2001
 
10) Radig K, Buhtz P, Rossner A : Alveolar soft part sarcoma of the uterine corpus : report of two cases and review of the literature. Pathol Res Paract 194 : 59-63, 1998
 
11) Folpe AL : Neoplasms with perivascular epithelioid cell differentiation (PEComas). in Fletcher CDM, Unni KK, Mertens F (eds) : "WHO Classification of Tumours of Soft Tissue and Bone". IARC Press, Lyon, 2002, pp221-222
 
12) Folpe AL, Mentzel T, Lehr HA et al : Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin. A clinicopathologic study of 26 cases and review of the literature, Am J Surg Pathol 29 : 1575-1585, 2005
 
13) Schoolmeester JK, Howitt BE, Hirsch MS et al : Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract : clinicopathologic and immunohistochemical characterization of 16 cases. Am J Surg Pathol 38 : 176-188, 2014
PubMed
14) Fukunaga M : Perivascular epithelioid cell tumor of the uterus : report of four cases. Int J Gynecol Pathol 24 : 341-346, 2005
PubMed
15) Fadare O : Perivascular epithelioid cell tumor (PEComa) of the uterus : an outcome-based clinicopathologic analysis of 41 reported cases. Adv Anat Pathol 15 : 63-67, 2008
PubMed
16) Silva EG, Deavers MT, Bodurka DC et al : Uterine epithelioid leiomyosarcomas with clear cells : reactivity with HMB-45 and the concept of PEComa. Am J Surg Pathol 28 : 244-249, 2004
PubMed
17) Kaskin WS, Fetsch, JF, Tavassoli FA : Superficial cervicovaginal myofibroblastoma : fourteen cases of distinctive mesenchymal tumor arising from the specialized subepithelial stromal of the lower female genital tract. Hum Pathol 32 : 215-225, 2001
 
18) Ganesan R, McCluggage WG, Hirschowitz L et al : Superficial myofibroblastoma of the lower female genital tract : report of a series including tumours with a vulval location. Histopathology 46 : 137-143, 2005
PubMed
19) Nucci MR, McCullage, Nielsen GP et al : Mesenchymal tumours and tumour-like lesions, in Kurman RJ, Carcangiu M, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed. IARC Press, Lyon, 2014, pp218-221
 
20) Clement PB, Young RH, Scully RE : Stromal endometriosis of the uterine cervix : a variant of endometriosis that may simulate a sarcoma. Am J Surg Pathol 14 : 449-455, 1990
PubMed
21) Fukunaga M : Catamenial pneumothorax caused by diaphragmatic stromal endometriosis. APMIS 107 : 635-638, 1999
 
P.145 掲載の参考文献
1) Gilks CB, Young RH, Clement PB et al : Adenomyomas of the uterine cervix of endocervical type : a report of ten cases of a benign cervical tumor that may be confused with adenoma malignum [corrected]. Mod Pathol 9 : 220-224, 1996
PubMed
2) Mikami Y, Maehata K, Fujiwara K et al : Endocervical adenomyoma. a case report with histochemical and immunohistochemical studies. APMIS 109 : 546-550, 2001
PubMed
3) Casey S, McCluggage WG : Adenomyomas of the uterine cervix : report of a cohort including endocervical and novel variants. Hisopathology 66 : 420-429, 2015
 
4) Matsuzaki S, Matsuzaki S, Tanaka Y et al : Large uterine cervical adenomyoma excised by vaginal approach : case report, images, and literature review. J Minim Invasive Gynecol 21 : 954-958, 2014
PubMed
5) Vershraegen CF, Vasuratna A, Eawards C et al : Clinicopathologic analysis of mullerian adenosarcoma : the M.D. Anderson Cancer Center experience. Oncol Rep 5 : 939-944, 1998
 
6) Jones MW, Lefkowitz M : Adenosarcoma of the uterine cervix : a clinicopathological study of 12 cases. Int J Gynecol Pathol 14 : 223-229, 1995
PubMed
7) McCluggage : Mullerian adenosarcoma of the female genital tract. Adv Anat Pathol 17 : 122-129, 2010
PubMed
8) Clement PB, Scully ER : Mullerian adenosarcoma of the uterus : a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 21 : 363-381, 1990
 
9) Gallardo A, Prat J : Mulerian adenosarcoma : a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. Am J Surg Pathol 33 : 278-288, 2009
 
10) Hodgson A, Amemiya Y, Seth A et al : High-grade Mullerian adenosarcoma : genomic and clinicopathologic characterization of a distinct neoplasm with prevalent TP53 pathway alterations and aggressive behavior. Am J Surg Pathol 41 : 1513-1522, 2017
PubMed
11) Soslow RA, Ali A, Oliva E : Mullerianadenosarcomas : an immunophenotypic analysis of 35 cases. Am J Surg Pathol 32 : 1013-1021, 2008
PubMed
12) Dehner LP, Jarzembowski JA, Hill DA : Embryonal rhabdomyosarcoma of the uterine cervix : a report of 14 cases and a discussion of its unusual clinicopathological associations. Mod Pathol 25 : 602-614, 2012
 
13) Foulkes WD, Bahubeshi A, Hamel N et al : Extending the phenotypes associated with DICER1 mutations. Hum Mutat 32 : 1381-1384, 2011
PubMed
14) Mumba E, Ali H, Turton D et al : Human papillomaviruses do not play an aetiological role in Mullerian adenosarcomas of the uterine cervix. J Clin Pathol 61 : 1041-1044, 2008
 
15) Nucci MR, Oliva E, Carcangiu ML et al : Mixed epithelial and mesenchymal tumours. in Kurman RJ, Carcangiu ML, Herrington CS (eds) : "WHO Classification of Tumours of Female Reproductive Organs". IARC Press, Lyon, 2014, pp202-203
 
16) Howitt BE, Sholl LM, Dal Cin P et al : Targeted genomic analysis of Mullerian adenosarcoma. J Pathol 235 : 37-49, 2015
PubMed
17) Lee JC, Lu TP, Changou CA et al : Genomewide copy number analysis of Mullerian adenosarcoma identified chromosomal instability in the aggressive subgroup. Mod Pathol 29 : 1070-1082, 2016
PubMed
18) Piscuoglio S, Burke KA, Ng CK et al : Uterine adenosarcomas are mesenchymal neoplasms. J Pathol 238 : 381-388, 2016
PubMed
19) Yuan CT, Huang WC, Lee CH et al : Comprehensive screening for MED12 mutations in gynaecological mesenchymal tumours identified morphologically distinctive mixed epithelial and stromal tumours. Histopathology 70 : 954-965, 2017
PubMed
20) Clement PB, Zubovits JT, Young RH et al : Malignant mullerian mixed tumors of the uterine cervix : a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus. Int J Gynecol Pathol 17 : 211-222, 1998
PubMed
21) Grayson W, Taylor LF, Cooper K. : Carcinosarcoma of the uterine cervix : a report of eight cases with immunohistochemical analysis and evaluation of human papillomavirus status. Am J Surg Pathol 25 : 338-347, 2001
PubMed
22) Sharma NK, Sorosky JI, Bender D et al. Malignant mixed mullerian tumor (MMMT) of the cervix. Gynecol Oncol 97 : 442-445, 2005
PubMed
23) de Brito PA, Silverberg SG, Orenstein JM : Carcinoma (malignant mixed muullerian (mesodermal) tumor) of the female genital tract : immunohitochemical and ultrastructural analysis of 28 cases. Human Pathol 24 : 132-142, 1993
 
24) McConechy MK, Hoang LN, Chui MH et al : In-depth molecular profiling of the biphasic components of uterine carcinosarcoma. J Pathol Clin Res 9 : 173-185, 2015
 
25) Chiyoda T, Tsuda H, Tanaka H et al : Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma? Genes Chromosomes Cancer 51 : 229-239, 2012
PubMed
26) Chemiack AD, Shen H, Walter V et al : Integrate molecular characterization of uterine carcinosarcoma. Cancer Cell 31 : 411-423, 2017
 
P.148 掲載の参考文献
1) Uehara T, Takayama S, Takemura T et al : Foci of stromal melanocytes (so-called blue naevus) of the uterine cervix in Japanese women. Virchows Arch A Pathol Anat Histopathol 418 : 327-331, 1991
PubMed
2) Saikia UN, Dey P, Saikia B et al : Melanin containing cells of the uterine cervix and a possible histogenesis. a case report. Indian J Pathol Microbiol 47 : 22-23, 2004
 
3) Venyo LKG, Fatola CO, Venyo AKG : Melanoma of the Uterus : A Review of the Literature. IJWHR 3 : 2-12, 2015
 
4) Singh N, Tripathi R, Mala YM : Primary malignant melanoma of uterine cervix with probable origin from benign cervical melanosis. BMJ Case Repor ts 2013 ; doi : 10.1136/bcr-2013-010042
 
5) Cid JM : Melanoid pigmentation of the endocervix : a neurogenic visceral argument. Ann Anat Pathol 4 : 617-628, 1959
PubMed
6) Hall DJ, Schneider V, Goplerud DR : Primary malignant melanoma of the uterine cervix. Obstet Gynecol 56 : 525-529, 1980
PubMed
7) Clark KC1, Butz WR, Hapke MR : Primary malignant melanoma of the uterine cervix : case report with world literature review. Int J Gynecol Pathol 18 : 265-273, 1999
 

第3部 鑑別ポイント

P.160 掲載の参考文献
1) Mutter GL, Prat J : Pathology of the Female Reproductive Tract. Churchill Livingstone Elsevier Chapter 8, Cervical Benign and Non-Neoplastic Conditions, 2014
 
2) Herfs M, Yamamoto Y, Laury A et al : A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci U S A 109 : 10516-10521, 2012
PubMed
3) Crum CP, Egawa K, Fu YS et al : Atypical immature metaplasia (AIM). A subset of human papilloma virus infection of the cervix. Cancer 51 : 2214-2219, 1983
 
4) Duggan MA, Akbari M, Magliocco AM : Atypical immature cervical metaplasia : immunoprofiling and longitudinal outcome. Hum Pathol 37 : 1473-1481, 2006
PubMed
5) Park JJ, Sun D, Quade BJ et al : Stratified mucin-producing intraepithelial lesions of the cervix : adenosquamous or columnar cell neoplasia? Am J Surg Pathol 24 : 1414-1419, 2000
PubMed
P.166 掲載の参考文献
1) Ayre JE : The vaginal smear ; precancer cell studies using a modified technique. Am J Obstet Gynecol 58 : 1205-1219, 1949
PubMed
2) Koss LG, Durfee GR : Unusual patterns of squamous epithelium of the uterine cervix : cytologic and pathologic study of koilocytotic atypia. Ann NY Acd Sci 63 : 1245-1261, 1956
 
3) Della Torre G, Pilotti S, de Palo G et al : Viral particles in cervical condylomatous lesions. Tumori 64 : 549-553, 1978
PubMed
4) Herrington CS, Baak JPA, Mutter GL : Cervical squamous intraepithelial lesions. in Mutter GL, Prat JMD (eds) : "Pathology of the Female Reproductive Tract", 3rd ed. Churchill Livingstone/Elsevier, Philadelphia, 2014, pp200-231
 
5) Darragh TM, Colgan TJ, Cox JT et al : The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions : background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pahol Lob Med 136 : 1266-1297, 2012
 
6) Stoler M, Kim KR, Bergeron C et al : Squamous cell tumours and precursors. in Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed. IARC Press, Lyon, 2014, pp172-182
 
7) Hudelist G, Manavi M, Pischinger KI et al : Physical state and expression of HPV DNA in benign and dysplastic cervical tissue : different levels of viral integration are correlated with lesion grade. Gynecol Oncol 92 : 873-880, 2004
PubMed
8) Meisels A, Fortin R : Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. Acta Cytol 20 : 505-509, 1976
 
9) Meisels A, Fortin R, Roy M : Condylomatous lesions of the cervix. II. Cytologic, colposcopic and histopathologic study. Acta Cytol 21 : 379-390, 1977
PubMed
10) Dyson JL, Walker PG, Singer A : Human papillomavirus infection of the uterine cervix : histological appearances in 28 cases identified by immunohistochemical techniques. J Clin Pathol 37 : 126-130, 1984
PubMed
11) Jovanovic AS, McLachlin CM, Shen L et al : Postmenopausal squamous atypia : a spectrum including "pseudokoilocytosis". Mod Pathol 8 : 408-412, 1995
PubMed
12) Val-Bernal JF, Pinto J, Garijo MF et al : Pagetoid dyskeratosis of the cervix : an incidental histologic finding in uterine prolapse. Am J Surg Pathol 24 : 1518-1523, 2000
PubMed
P.174 掲載の参考文献
1) Kurmann RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed. IARC Press, Lyon, 2014, pp169-206
 
2) 日本産婦人科学会, 日本病理学会, 日本医学放射線学会, 日本放射線腫瘍学会 (編) : 子宮頸癌取扱い規約, 第3版, 金原出版, 2012
 
3) Rodrigues L, Santana I, Cunha T et al : Sarcomatoid squamous cell carcinoma of the uterine cervix : case report. Eur J Gynaecol Oncol 21 : 287-289, 2000
PubMed
4) Rekhi B, Patil B, Deodhar KK et al : Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India. Ann Diagn Pathol 17 : 1-9, 2013
 
5) Gilks CB, Young RH, Gersell DJ, Clement PB et al : Large cell neuroendocrine [corrected] carcinoma of the uterine cervix : a clinicopathologic study of 12 cases. Am J Surg Pathol, 21 : 905-914, 1997
PubMed
6) Lopez-Rios F, Miguel PS, Bellas C et al : Lymphoepithelioma-like carcinoma of the uterine cervix : a case report studied by in situ hybridization and polymerase chain reaction for Epstein-Barr virus. Arch Pathol Lab Med 124 : 746-747, 2000
PubMed
7) Noel J, Lespagnard L, Fayt I et al : Evidence of human papilloma virus infection but lack of Epstein-Barr virus in lymphoepithelioma-like carcinoma of uterine cervix : report of two cases and review of the literature. Hum Pathol 32 : 135-138, 2001
PubMed
8) Zhang X, Lu W, Lu B : Epithelioid trophoblastic tumor : an outcome-based literature review of 78 reported cases. Int J Gynecol Cancer 23 : 1334-1338, 2013
PubMed
9) Grayson W, Taylor LF, Cooper K : Adenoid Cystic and Adenoid Basal Carcinoma of the Uterine Cervix : Comparative Morphologic, Mucin, and Immunohistochemical Profile of Two Rare Neoplasms of Putative 'Reserve Cell' Origin. Am J Surg Pathol 23 : 448-458, 1999
PubMed
10) Chang A, Amin A, Gabrielson E et al : Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol 36 : 1472-1476, 2012
PubMed
11) Tatsumori T, Tsuta K, Masai K et al : p40 is the best marker for diagnosing pulmonary squamous cell carcinoma : comparison with p63, cytokeratin 5?6, desmocollin-3, and sox2. Appl Immunohistochem Mol Morphol 22 : 377-382, 2014
PubMed
12) Wong S, Hong W, Hui P et al : Comprehensive Analysis of PAX8 Expression in Epithelial Malignancies of the Uterine Cervix. Int J Gynecol Pathol 36 : 101-106, 2017
PubMed
P.180 掲載の参考文献
1) Riethdorf L, Riethdorf S, Lee KR et al : Human papillomaviruses, expression of p16INK4A, and early endocervical glandular neoplasia. Hum Pathol 33 : 899-904, 2002
 
2) Wilbur DC, Mikami Y, Colgan TJ et al : Glandular tumours and precursors, in Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : "WHO Classification of Tumours of Female Reproductive Organs", 4th ed. IARC Press, Lyon, 2014, pp183-194
 
3) Tringler B, Gup CJ, Singh M et al : Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol 35 : 689-696, 2004
PubMed
4) Programme NCS : Histopathology Reporting in Cancer Screening. NHSCSP Publication, Sheffield, 2012
 
5) McCluggage WG : New development in endocervical glandular lesions. Histopathology 62 : 138-160, 2013
 
P.190 掲載の参考文献
1) Kurman RJ, Carcangiu ML, Herrington CS et al (eds) : WHO Classification of Tumours of Female Reproductive Organs, 4th ed. IARC Press, Lyon, 2014, pp126-128, 184-188
 
2) Yemelyanova A, Vang R, Seidman JD et al : Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas : utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Am J Surg Pathol 33 : 914-924, 2009
PubMed
3) Tambouret R, Clement PB, Young RH : Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix : a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion. Am J Surg Pathol 27 : 1080-1088, 2003
PubMed
4) Ramirez PT, Frumovitz M, Milam MR et al : Limited utility of magnetic resonance imaging in determining the primary site of disease in patients with inconclusive endometrial biopsy. Int J Gynecol Cancer 20 : 1344-1349, 2010
PubMed
5) Loureiro J, Oliva E : The spectrum of cervical glandular neoplasia and issues in differential diagnosis. Arch Pathol Lab Med 138 : 4534-4583, 2014
 
6) McCluggage WG : New developments in endocervical glandular lesions. Histopathology 62 : 138-160, 2013
PubMed
7) Park HM, Lee SS, Eom DW et al : Endometrioid adenocarcinoma arising from endometriosis of the uterine cervix : a case report. J Korean Med Sci 24 : 767-771, 2009
PubMed
8) Ansari-Lari MA, Staebler A, Zaino RJ et al : Distinction of endocervical and endometrial adenocarcinomas : immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol 28 : 160-167, 2004
PubMed
9) Staebler A, Sherman ME, Zaino RJ et al : Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas. Am J Surg Pathol 26 : 998-1006, 2002
PubMed
10) Jiang L, Malpica A, Deavers MT et al : Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix : some cases probably represent independent primaries. Int J Gynecol Pathol 29 : 146-156, 2010
PubMed
11) Hachisuga T, Fukuda K, Iwasaka T et al : Endometrioid adenocarcinomas of the uterine corpus in women younger than 50 years of age can be divided into two distinct clinical and pathologic entities based on anatomic location. Cancer 92 : 2578-2584, 2001
PubMed
12) Watanabe Y, Nakajima H, Nozaki K et al : Clinicopathologic and immunohistochemical features and microsatellite status of endometrial cancer of the uterine isthmus. Int J Gynecol Pathol 20 : 368-373, 2001
PubMed
13) Westin SN, Lacour RA, Urbauer DL et al : Carcinoma of the lower uterine segment : a newly described association with Lynch syndrome. J Clin Oncol 26 : 5965-5971, 2008
PubMed
14) Masuda K, Banno K, Yanokura M et al : Carcinoma of the Lower Uterine Segment (LUS) : Clinicopathological Characteristics and Association with Lynch Syndrome. Curr Genomics 12 : 25-29, 2011
PubMed
15) Rabban JT, Calkins SM, Karnezis AN et al : Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients : implications for universal versus selective screening strategies for Lynch syndrome. Am J Surg Pathol 38 : 793-800, 2014
PubMed
16) Mills AM, Liou S, Ford JM et al : Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Am J Surg Pathol 38 : 1501-1509, 2014
PubMed
P.200 掲載の参考文献
1) Galgano MT, Castle PE, Atkins KA et al : Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 34 : 1077-1087, 2010
 
2) Darragh TM, Colgan TJ, Cox JT et al : The lower anogenital squamous terminaly standardization project for HPV-associated lesions : background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol 32 : 76-115, 2013
 
3) Shih IM, Kurman RJ : p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol 28 : 1177-1183, 2004
PubMed
4) Carleton C, Hoang L, Sah S et al : A detailed immunohistochemical analysis of a large series of cervical and vaginal gastric-type adenocarcinomas. Am J Surg Pathol 40 : 636-644, 2016
 
5) Maniar KP, Sanchez B, Paintal A et al : Role of the biomarker p16 in downgrading-IN 2 diagnoses and predicting higher-grade lesions. Am J Surg Pathol 39 : 1708-1718, 2015
PubMed
6) Miralpeix E, Genoves J, Solw-Sedeno M et al : Usefulness of p16INK4a staining for managing histological high-grade squamous intraepithelial cervical lesions. Mod Pathol 30 : 304-310, 2017
 
7) Ozaki S, Zen Y, Inoue M : Biomarker expression in cervical intraepithelial neoplasia : potential progression predictive factors for low-grade lesions. Hum Pathol 42 : 1007-1012, 2011
PubMed
8) Sagasta A, Castillo P, Saco A et al : p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix. Mod Pathol 29 : 51-59, 2016
PubMed
9) Paquette C, Mills AM, Stoler MH : Predictive value of cytokeratin 7 immunohistochemistry in cervical low-grade squamous intraepithelial lesion as a marker for risk of progression to a high-grade lesion. Am J Surg Pathol 40 : 236-243, 2016
PubMed

第4部 臨床との連携

P.208 掲載の参考文献
1) Gasparini R, Panatto D : Cer vical cancer : from Hippocrates through Rigoni-Stern to zur Hausen. Vaccine 27 (Suppl 1) : A4-A5, 2009
 
2) 片渕秀, 岡村均 : 注目の領域 妊娠・分娩, 性生活の変化は婦人科腫瘍の発生を変える. 医学のあゆみ 190 : 779-788, 1999
 
3) Singer A : Genital herpes and cervical cancer. Br Med J 1 : 458, 1971
 
4) zur Hausen H : Condylomata acuminata and human genital cancer. Cancer Res 36 : 794, 1976
PubMed
5) Schwarz E, Freese UK, Gissmann L et al : Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314 : 111-114, 1985
PubMed
6) Ho L, Chan SY, Burk RD et al : The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 67 : 6413-6423, 1993
PubMed
7) Ong CK, Chan SY, Campo MS et al : Evolution of human papillomavirus type 18 : an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 67 : 6424-6431, 1993
PubMed
8) Broders AC : Carcinoma in situ contrasted with benign penetration epithelium. JAMA 99 : 1670-1674, 1932
 
9) Worldwide data : World cancer research fund international ; 2012. Available from : http://www.wcrf.org/int/cancer-facts-figures/worldwide-data
 
10) Hori M, Matsuda T, Shibata A et al : Cancer incidence and incidence rates in Japan in 2009 : a study of 32 populationbased cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 45 : 884-891, 2015
 
11) Scheller NM, Pasternak B, Molgaard-Nielsen D et al : Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes. N Engl J Med 376 : 1223-1233, 2017
PubMed
12) Pollock KG, Kavanagh K, Potts A et al : Reduction of lowand high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland. Br J Cancer 111 : 1824-1830, 2014
 
13) Brotherton JM, Gertig DM, May C et al : HPV vaccine impact in Australian women : ready for an HPV-based screening program. Med J Aust 204 : 184-184e1, 2016
PubMed
14) Flagg EW, Torrone EA, Weinstock H : Ecological Association of Human Papillomavirus Vaccination with Cervical Dysplasia Prevalence in the United States, 2007-2014. Am J Public Health 106 : 2211-2218, 2016
PubMed
P.214 掲載の参考文献
1) Bzhalava D, Eklund C, Dillner J : International standardization and classification of human papillomavirus types. Virology 476 : 341-344, 2015
PubMed
2) Doorbar J : Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 110 : 525-541, 2006
PubMed
3) Moscicki AB, Schiffman M, Burchell A et al : Updating the natural history of human papillomavirus and anogenital cancer. Vaccine 30 : 24-33, 2012
 
4) 笹川寿之 : 宿主免疫応答の視点からのHPV発癌のメカニズム. 産婦の実際 65 : 1471-1479, 2017
 
5) Zhou Q, Zhu K, Cheng H : Toll-like receptors in human papillomavirus infection. Arch Immunol Ther Exp (Warsz) 61 : 203-215, 2013
PubMed
6) Nakagawa M, Gupta SK, Coleman HN et al : A favorable clinical trend is associated with CD8 T-cell immune responses to the human papillomavirus type 16 E6 antigens in women being studied for abnormal pap smear results. J Low Genit Tract Dis 14 : 124-129, 2010
PubMed
7) Dillon S, Sasagawa T, Crawford A et al : Resolution of cervical dysplasia is associated with T-cell proliferative responses to human papillomavirus type 16 E2. J Gen Virol 88 : 803-813, 2007
 
8) Kim KH, Greenfield WW, Cannon MJ et al : CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend. Cancer Immunol Immunother 61 : 63-70, 2012
PubMed
9) Nees M, Geoghegan JM, Hyman T et al : Papillomavirus type 16 oncogenes downregulate expression of interferonresponsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocyte. J Virol 75 : 4283-4296, 2001
PubMed
10) Reiser J, Hurst J, Voges M et al : High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression. J Virol 85 : 11372-11380, 2011
PubMed
11) Hasan UA, Bates E, Takeshita F et al : TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J Immunol 178 : 3186-3197, 2007
PubMed
12) Sasagawa T, Yamazaki H, Dong YZ et al : Immunoglobulin-A and-G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions. Int J Cancer 75 : 529-535, 1998
 
13) Sasagawa T, Rose RC, Azar KK et al : Mucosal immunoglobulin-A and-G responses to oncogenic human papilloma virus capsids. Int J Cancer 104 : 328-335, 2003
 
14) Sasagawa T, Inoue M, Tanizawa O et al : Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias. Jpn J Cancer Res 83 : 705-713, 1992
PubMed
15) Tindle RW : Immune evasion in human papillomavirus-associated cervical cancer. Nat Rev Cancer 2 : 59-65, 2002
PubMed
16) Moerman-Herzog A, Nakagawa M : Early Defensive Mechanisms against Human Papillomavirus Infection. Clin Vaccine Immunol 22 : 850-857, 2015
PubMed
17) Sasagawa T, Kondoh G, Inoue M et al : Cervical/vaginal dysplasias of transgenic mice harbouring human papillomavirus type 16 E6-E7 genes. J Gen Virol 75 : 3057-3065, 1994
 
18) Brake T, Lambert PF : Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci USA 102 : 2490-2495, 2005
 
19) Herfs M, Yamamoto Y, Laury A et al : A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci USA 109 : 10516-10521, 2012
PubMed
20) Doorbar J : Model systems of human papillomavirus-associated disease. J Pathol 238 : 166-179, 2016
PubMed
21) Tyagi A, Vishnoi K, Mahata S et al : Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1. Clin Cancer Res 22 : 4170-4184, 2016
PubMed
22) Akagi K, Li J, Broutian TR et al : Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res 24 : 185-199, 2014
PubMed
23) Creasman WT, Phillips JL, Menck HR : The National Cancer Data Base report on cancer of the vagina. Cancer 83 : 1033-1040, 1998
PubMed
P.221 掲載の参考文献
1) 日本産科婦人科学会婦人科腫瘍委員会 : 子宮頸癌, 子宮体癌進行期分類の改訂について. 日産婦誌 64 : 1471-1477, 2012
 
2) 日本産科婦人科学会, 日本病理学会 (編) : 子宮頸癌取扱い規約 病理編 第4版. 金原出版, 2017
 
3) 日本婦人科腫瘍学会 (編) : 子宮頸癌治療ガイドライン2017年版. 金原出版, 2017
 
4) Brierley JD, Gospodarowicz MK, Wittekind C (eds) : TNM Classification of Malignant Tumours, 8th ed. Wiley-Blackwell, West Sussex, 2017, 166-170
 
5) 馬場長, 小西郁生 : 子宮がんに対する外科治療. 臨床と研究 93 : 819-825, 2016
Medical*Online
P.225 掲載の参考文献
1) Zannoni GF, Vellone VG, Carbone A : Morphological Effects of Radiochemotherapy on Cervical Carcinoma : A Morphological Study of 50 Cases of Hysterectomy Specimens After Neoadjuvant Treatment. Int J Gynecol Pathol 27 : 274-281, 2008
PubMed
2) Wright TC, Ronnett BM, Ferenczy A : Benign diseases of the cer vix. in Kurman RJ, Ellenson LH, Ronnett BM (eds) : "Blaustein's Pathology of the Female Genital Tract", 6th ed. Springer, New York, 2011, pp171
 
3) Cibas ES : Cervical and vaginal cytology. in Cibas ES, Ducatman BS (eds) : "Cytology : Diagnostic Principles and Clinical Correlates", 2nd ed. Saunders, Philadelphia, 2003, pp24-27
 
4) Koss LG, Melamed MR : Effects of therapeutic procedures on the epithelia of the female genital tract. in Koss LG, Melamed MR (eds) : "Koss' Diagnostic Cytology and its Histopathologic Bases", 5th ed. Lippincott Williams & Wilkins, Philadelphia, 2006, pp553-563
 
5) 加藤智美, 安田政実, 矢島沙紀 他 : 子宮頸部扁平上皮癌における放射線治療/化学療法の治療効果判定-細胞診の精度管理と報告のあり方-. 日臨細胞会誌 50 : 332-340, 2011
 
P.232 掲載の参考文献
1) Protocol for the Examination of Specimens From Patients With Carcinoma of the Uterine Cervix. http://www.cap.org/
 
2) Carcinoma of the Cervix-published March 2017. http://www.iccr-cancer.org
 
3) 日本産科婦人科学会, 日本病理学会 (編) : 子宮頸癌取扱い規約 病理編, 第4版. 金原出版, 2017
 
4) 『病理検体の取り違え事故に関する報告書』千葉県がんセンター 院内事故調査委員会2016年2月17日. https://www.pref.chiba.lg.jp/gan/oshirase/2015/documents/hokokusho01.pdf
 
5) Roma AA, Mistretta TA, Diaz De Vivar A et al : New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome. Gynecol Oncol 141 : 36-42, 2016
PubMed

書評

最近チェックした商品履歴

Loading...